Cleared Traditional

K870210 - CLEARVIEW CW-10

K870210 is the FDA 510(k) clearance for CLEARVIEW CW-10 by Clearview Instruments, Inc.. It is a Class 2 Hematology device (product code GKR) cleared through the Traditional 510(k) pathway after a 98-day FDA review.

K870210 · Clearview Instruments, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1987
Decision
98d
Days
Class 2
Risk

K870210 is an FDA 510(k) clearance for the CLEARVIEW CW-10. Classified as System, Hemoglobin, Automated (product code GKR), Class II - Special Controls.

Submitted by Clearview Instruments, Inc. (Stow, US). The FDA issued a Cleared decision on April 28, 1987 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5620 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Clearview Instruments, Inc. devices

Submission Details

510(k) Number K870210 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 20, 1987
Decision Date April 28, 1987
Days to Decision 98 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 113d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GKR System, Hemoglobin, Automated
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKR System, Hemoglobin, Automated

All 22
Devices cleared under the same product code (GKR) and FDA review panel - the closest regulatory comparables to K870210.
AVL OMNI ANALYZER
K954018 · Avl Scientific Corp. · Oct 1995
HEMOGLOBIN REAGENT
K910745 · Toa Medical Electronics USA, Inc. · Jul 1991
CIBA CORNING MODEL 280 PH/BLOOD GAS SYSTEM
K880353 · Ciba Corning Diagnostics Corp. · Jun 1988
HEMOGLOBIN REAGENT SET
K841057 · Medical Specialties, Inc. · Mar 1984
KING DIAGNOSTICS HEMOGLOBIN TEST
K812127 · King Diagnostics, Inc. · Aug 1981
HEMESPEC II
K803015 · Helena Laboratories · Dec 1980